Lesion-level effects of LDL-C–lowering therapy in patients with acute myocardial infarction
About The Study: At the lesion level, very intensive lipid-lowering therapy induced substantially greater percent atheroma volume regression than described in previous vessel-level analyses. Compared with statin therapy alone, alirocumab treatment was associated with greater enlargement of the lesion minimum lumen area and more frequent transition of presumably high-risk plaque phenotypes into more stable, less lipid-rich plaque phenotypes.
Corresponding Author: To contact the corresponding author, Lorenz ...






